Tuberculosis, pulmonary
Clinical trials for Tuberculosis, pulmonary explained in plain language.
Never miss a new study
Get alerted when new Tuberculosis, pulmonary trials appear
Sign up with your email to follow new studies for Tuberculosis, pulmonary, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could TB treatment be cut from 6 months to 17 weeks?
Disease control OngoingThis study tests whether two new 17-week drug combinations can treat pulmonary tuberculosis as effectively as the standard 6-month regimen. About 288 people with TB will receive one of three daily pill regimens. The goal is to see if shorter treatment can clear the infection fast…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase 2/3 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Sep 21, 2026 14:00 UTC
-
Can higher doses of TB drugs cut treatment time?
Disease control PausedThis phase II trial is investigating whether higher doses of two tuberculosis (TB) drugs, rifampicin and pyrazinamide, can safely shorten treatment for people with mild to moderate pulmonary TB. The study compares drug levels and safety of this high-dose regimen against the stand…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase 2 • Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a 12-Week pill cocktail replace 6 months of TB treatment?
Disease control OngoingThis phase 2 trial tests whether a 12-week combination of four drugs (bedaquiline, clofazimine, pyrazinamide, and delamanid) works better than the standard 26-week treatment for drug-susceptible tuberculosis. About 94 adults with TB will be randomly assigned to either the short r…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Pee test could spot TB patients skipping meds
Knowledge-focused By invitation onlyThis study in India will test a low-cost urine check (IsoScreen) on 900 adults being treated for tuberculosis. The test detects whether they have taken their medication recently. Researchers want to see if the test can reliably find people who are missing doses, so that doctors c…
Matched conditions: TUBERCULOSIS, PULMONARY
Sponsor: Tufts University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC